InMed Pharmaceuticals Inc.
|
|||
| Mailing Address: | #310-815 West Hastings St. Vancouver, British Columbia V6C 1B4 |
Head Office Address: | #310-815 West Hastings St. Vancouver, British Columbia V6C 1B4 |
| Contact Name: | Eric A. Adams | Principal Regulator: | British Columbia |
| Business e-mail address: | eadams@inmedpharma.com | Short Form Prospectus Issuer: | Yes |
| Telephone Number: | 604 669-7207 | Reporting Jurisdictions: | British Columbia, Alberta, Ontario |
| Fax Number: | 778 945-6800 | Stock Exchange: | NASDAQ |
| Date of Formation: | May 19 1981 | Stock Symbol: | INM |
| Jurisdiction Where Formed: | British Columbia | Auditor: | Marcum LLP |
| Industry Classification: | other | General Partner: | |
| CUSIP Number: | 457637 | Transfer Agent: | Odyssey Trust Company |
| Financial Year-End: | Jun 30 | Size of Issuer (Assets): | $5,000,001 to $25,000,000 |
|
